Skip to main content

Advertisement

Log in

Genotoxicity concerns for base and prime editors in hematopoietic stem cells

  • Research Briefing
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Although base and prime editors can be highly efficient in human hematopoietic stem cells, we find they can cause adverse cellular responses, including reduced engraftment and the generation of DNA double-strand breaks and genotoxic byproducts, albeit at a lower frequency than Cas9. We also find that base editors increase the genome-wide mutagenic load.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Multiparameter comparison of Cas9, BE and PE for editing HSPCs in vitro and in xenografts.

References

  1. Anzalone, A. V. et al. Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 38, 824–844 (2020). This review presents the different editing systems.

  2. Ferrari, S. et al. Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking. Nat Biotechnol. 38, 1298–1308 (2020). This paper reports the effect of Cas9-induced p53 activation on engraftment capacity of human HSPCs and graft clonality.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Park, S. H. et al. Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing. Sci. Adv. 8, eabo7676 (2022). This paper reports a comprehensive characterization of the unintended editing outcomes occurring at CRISPR–Cas9 target sites in HSPCs.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Everette, K. A. et al. Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. Nat. Biomed. Eng. 7, 616–628 (2023). This paper reports ex vivo prime editing in human HSPCs for the treatment of sickle cell disease.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zeng, J. et al. Therapeutic base editing of human hematopoietic stem cells. Nat. Med. 26, 535–541 (2020). This paper reports ex vivo base editing in human HSPCs for the treatment of hemoglobinopathies.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Fiumara, M. et al. Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01915-4 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Genotoxicity concerns for base and prime editors in hematopoietic stem cells. Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-01916-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41587-023-01916-3

  • Springer Nature America, Inc.

Navigation